Japanese BAY80-6946 Monotherapy Phase I Study

NCT01404390 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
10
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bayer